Ozone Pharmaceuticals CMD launches his latest book 13 Prescriptions for Success in Life

New Delhi: SC Sehgal, Chairman and Managing Director of Ozone Pharmaceuticals, unveiled his much-awaited book 13 Prescriptions for Success in Life at Le Meridien, New Delhi, on Thursday. Published by Notion Press, the book was officially released on August 27 across major e-commerce platforms, including Notionpress.com.

Drawing upon decades of entrepreneurial leadership and personal reflection, Sehgal distilled his philosophy that “to succeed you need strength, but to sustain success you need humility.” The work, positioned as much a guide for boardrooms as for life, encapsulates learnings gathered through experience, setbacks, and growth.

The launch was graced by Dr. Kiran Bedi, India’s first woman IPS officer, who attended as Chief Guest. Lauding the book, she said, “The outlook for any enterprise must be growth with service, not status. Power is best reflected in the way it serves people, not in the position it commands. This book is filled with quotable quotes that, when reread daily, offer new perspective. I hope Ozone grows by leaps and bounds, becomes synonymous with Make in India and Make for the World, and continues to generate employment, service, and pride for the nation.”

Sehgal described the work as “not prescriptions from a pedestal, but experiential learning.” He emphasized that the book is a humble attempt to provide readers with a compass to grow with discipline, service, and purpose.

From a modest beginning, Sehgal has steered Ozone Pharmaceuticals into one of India’s most respected pharma companies. With revenues poised to reach Rs 1,000 crore, Ozone today symbolizes the Make in India dream—Indian in heart, global in vision. That same ethos informs the book: success means responsibility to create lasting impact and legacy.

Related Posts

English alphabets can’t be trademarked: Delhi HC

New Delhi: The Delhi High Court recently held that English alphabets cannot be monopolised through trademark law and refused interim protection to the mark ‘A TO Z’ used by a pharmaceutical…

IIT Roorkee develops next-generation antibody discovery platform

Dehradun: In a significant step towards affordable healthcare, pandemic preparedness, and indigenous biotechnology innovation, the Indian Institute of Technology Roorkee (IIT Roorkee) has developed a next-generation antibody discovery platform with…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

English alphabets can’t be trademarked: Delhi HC

English alphabets can’t be trademarked: Delhi HC

IIT Roorkee develops next-generation antibody discovery platform

IIT Roorkee develops next-generation antibody discovery platform

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025

CDSCO approves highest number of new drugs with r-DNA origin for import & manufacture in 2025

Spiralling Gold And Silver Prices Impact Costs Of Ayurvedic Medicines With Traces Of Precious Metals

Spiralling Gold And Silver Prices Impact Costs Of Ayurvedic Medicines With Traces Of Precious Metals

Chhattisgarh eyes investments with high-incentive policy and dedicated pharma park

Chhattisgarh eyes investments with high-incentive policy and dedicated pharma park

CDSCO to dispose online applications pending for more than two years

CDSCO to dispose online applications pending for more than two years